The diagnosis and treatment of SIBO in Latin America
DOI:
https://doi.org/10.56294/shp202210Keywords:
SIBO, diagnosis, breath test, treatment, Latin AmericaAbstract
The small intestine normally harboured a limited amount of bacteria, but in SIBO there was an abnormal proliferation of microorganisms, especially in the jejunum. This condition generated various symptoms such as abdominal distension, diarrhoea and malabsorption, which made it difficult to diagnose. The lactulose or glucose breath test has become established as a useful non-invasive technique for its detection, although its implementation in Latin America presented challenges related to access, standardisation and professional training. Appropriate treatment included antibiotics such as rifaximin, a specific diet and prokinetics to prevent relapses. Despite the progress made, obstacles persisted in the region that required further research and the strengthening of clinical guidelines.
References
1. Baker JR, Chey WD, Watts L, Armstrong M, Collins K, Lee AA, et al. How the North American Consensus Protocol Affects the Performance of Glucose Breath Testing for Bacterial Overgrowth Versus a Traditional Method. Am J Gastroenterol. 2021 Apr;116(4):780–7. doi: 10.14309/ajg.0000000000001110. PMID: 33982948.
2. Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010 Jun 28;16(24):2978–90. doi: 10.3748/wjg.v16.i24.2978. PMID: 20572300; PMCID: PMC2890937.
3. Bushyhead D, Quigley EM. Small Intestinal Bacterial Overgrowth. Gastroenterol Clin North Am. 2021 Jun;50(2):463–74. doi: 10.1016/j.gtc.2021.02.008. PMID: 34024452.
4. Bushyhead D, Quigley EMM. Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management. Gastroenterology. 2022 Sep;163(3):593–607. doi: 10.1053/j.gastro.2022.04.002. PMID: 35398346.
5. Chatterjee S, Park S, Low K, Kong Y, Pimentel M. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol. 2007 Apr;102(4):837–41. doi: 10.1111/j.1572-0241.2007.01072.x. PMID: 17397408.
6. Gabrielli M, D'Angelo G, Di Rienzo T, Scarpellini E, Ojetti V. Diagnosis of small intestinal bacterial overgrowth in the clinical practice. Eur Rev Med Pharmacol Sci. 2013;17 Suppl 2:30–5. PMID: 24443065.
7. Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco G, et al.; 1st Rome H2-Breath Testing Consensus Conference Working Group. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009 Mar 30;29 Suppl 1:1–49. doi: 10.1111/j.1365-2036.2009.03951.x. Erratum in: Aliment Pharmacol Ther. 2010 Jan;31(1):166. Satta PU [corrected to Usai-Satta P]. PMID: 19344474.
8. Ghoshal UC, Nehra A, Mathur A, Rai S. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome. J Gastroenterol Hepatol. 2020 Jun;35(6):922–31. doi: 10.1111/jgh.14938. PMID: 31750966.
9. Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008 Jun;53(6):1443–54. doi: 10.1007/s10620-007-0065-1. PMID: 17990113.
10. Leite G, Rezaie A, Mathur R, Barlow GM, Rashid M, Hosseini A, et al.; REIMAGINE Study Group. Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing. Clin Gastroenterol Hepatol. 2024 Feb;22(2):259–70. doi: 10.1016/j.cgh.2023.06.001. PMID: 37315761.
11. Losurdo G, Leandro G, Ierardi E, Perri F, Barone M, Principi M, et al. Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis. J Neurogastroenterol Motil. 2020 Jan 30;26(1):16–28. doi: 10.5056/jnm19113. PMID: 31743632.
12. Magge S, Lembo A. Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y). 2012 Nov;8(11):739–45. PMID: 24672410; PMCID: PMC3966170.
13. Martín Domínguez V, Malagelada C, Santander C. Small intestinal bacterial overgrowth. A position paper of ASENEM-SEPD. Rev Esp Enferm Dig. 2023 Dec;115(12):679–81. doi: 10.17235/reed.2023.10027/2023. PMID: 37982553.
14. Quigley EMM. The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO). Curr Gastroenterol Rep. 2019 Jan 15;21(1):3. doi: 10.1007/s11894-019-0671-z. PMID: 30645678.
15. Quigley EMM, Murray JA, Pimentel M. AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review. Gastroenterology. 2020 Oct;159(4):1526–32. doi: 10.1053/j.gastro.2020.06.090. PMID: 32679220.
16. Rao SSC, Bhagatwala J. Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management. Clin Transl Gastroenterol. 2019 Oct;10(10):e00078. doi: 10.14309/ctg.0000000000000078. PMID: 31584459; PMCID: PMC6884350.
17. Ruscio M. Is SIBO A Real Condition? Altern Ther Health Med. 2019 Sep;25(5):30–8. PMID: 31550680.
18. Suárez Terán J, Guarner Aguilar F. Small Intestinal Bacterial Overgrowth (SIBO), a clinically overdiagnosed entity? Gastroenterol Hepatol. 2024 May 6:S0210-5705(24)00148-1. doi: 10.1016/j.gastrohep.2024.502190. PMID: 38719183.
19. Codoceo Alquinta R, Muñoz Codoceo C, Ariza Astolfi MJ, Muñoz Codoceo RA. Test del hidrógeno (H) espirado: Metodología e indicaciones [Internet]. Seghnp.org. [citado el 16 de octubre de 2024]. Disponible en: https://www.seghnp.org/sites/default/files/2020-02/Test%20hidrogeno%20espirado_2.pdf.
Published
Issue
Section
License
Copyright (c) 2022 Michelle Jésica Saín, Diego Balcarce (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
